Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 1075 of 2873 entries
View as:

Urelumab (CD137 mAb) With Rituximab for Relapsed, Refractory or High-risk Untreated Chronic Lymphocytic Leukemia (CLL) Patients

Phase: N/A Priority: Normal
NCT ID: NCT02420938 Org: User:
Start: 07/31/15 End: - Due: -

Study of Three Different Schedules of Low-Dose Decitabine in Myelodysplastic Syndrome (MDS)

Phase: N/A Priority: Normal
NCT ID: NCT00067808 Org: User:
Start: 10/31/03 End: 05/31/09 Due: 05/31/10

Multimedia Patient Education

Phase: N/A Priority: Normal
NCT ID: NCT01184534 Org: User:
Start: 08/31/10 End: 12/31/12 Due: 12/31/13

Study of Vemurafenib, Carboplatin, and Paclitaxel

Phase: N/A Priority: Normal
NCT ID: NCT01636622 Org: User:
Start: 07/09/12 End: 04/21/20 Due: 04/21/21

Web-Based Family Outreach Program for Cancer Prevention in High-Risk Families

Phase: N/A Priority: Normal
NCT ID: NCT02337452 Org: User:
Start: 04/10/15 End: 04/30/48 Due: 04/30/49

Well-Being and Health-Related Quality of Life in Cancer Patients and Survivors During the COVID-19 Pandemic

Phase: N/A Priority: Normal
NCT ID: NCT04500600 Org: User:
Start: 06/11/20 End: 04/30/27 Due: 04/30/28

Image-guided Proton Therapy for the Treatment of Locally Advanced Unresectable Head and Neck Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04870840 Org: User:
Start: 10/19/20 End: 07/11/23 Due: 07/11/24

A Single-Arm Study of Pembrolizumab With Gemcitabine and Cisplatin as Perioperative Therapy for Potentially Resectable Intrahepatic Cholangiocarcinoma

Phase: N/A Priority: Normal
NCT ID: NCT05967182 Org: User:
Start: 01/16/24 End: 07/31/29 Due: 07/31/30

The Effect of Yogurt in Cancer Patient With Moderate Gastrointestinal (GI) Symptoms

Phase: N/A Priority: Normal
NCT ID: NCT03177681 Org: User:
Start: 03/01/22 End: 03/21/23 Due: 03/21/24

Long Term Minor Sibling Donor Well-Being

Phase: N/A Priority: Normal
NCT ID: NCT00667784 Org: User:
Start: 04/30/08 End: 04/30/11 Due: 04/30/12

Fosaprepitant in Patients Receiving Ifosfamide-based Regimen

Phase: N/A Priority: Normal
NCT ID: NCT01490060 Org: User:
Start: 05/31/12 End: 03/31/16 Due: 03/31/17

Tissue Repair in Stem Cell Transplant Recipients

Phase: N/A Priority: Normal
NCT ID: NCT00501228 Org: User:
Start: 02/28/03 End: 09/30/08 Due: 09/30/09

Daptomycin in the Treatment of Catheter-Related Staphylococcus Aureus

Phase: N/A Priority: Normal
NCT ID: NCT00507247 Org: User:
Start: 05/31/06 End: 09/30/12 Due: 09/30/13

Accelerated Recovery After MIS Hepatectomy (ARAMIS Hep) to Support Early Discharge for Patients Undergoing Minimally Invasive Liver Resection

Phase: N/A Priority: Normal
NCT ID: NCT05879159 Org: User:
Start: 10/05/23 End: 02/01/27 Due: 02/01/28

Optimized Cord Blood Transplantation for the Treatment of Patients With High-risk Hematologic Malignancies Who Have Relapsed After First Allogeneic Stem Cell Transplantation

Phase: N/A Priority: Normal
NCT ID: NCT06807606 Org: User:
Start: 03/03/25 End: 11/30/29 Due: 11/30/30

A Pilot "Window-3" Study of Acalabrutinib Plus Rituximab Followed by Brexucabtagene Autoleucel Therapy in Patients With Previously Untreated High-risk Mantle Cell Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT05495464 Org: User:
Start: 11/18/22 End: 03/31/27 Due: 03/31/28

Lenalidomide and Darbepoetin in Low-Intermediate Risk Myelodysplastic Syndrome (MDS)

Phase: N/A Priority: Normal
NCT ID: NCT01222195 Org: User:
Start: 02/29/08 End: 07/31/10 Due: 07/31/11

Breast Magnetic Resonance Imaging (MRI) Screening After Mantle Radiation Therapy

Phase: N/A Priority: Normal
NCT ID: NCT00925405 Org: User:
Start: 06/30/09 End: 10/31/11 Due: 10/31/12

Paclitaxel and Bevacizumab With or Without Emactuzumab in Treating Patients With Platinum-Resistant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02923739 Org: User:
Start: 05/05/17 End: 09/27/22 Due: 09/27/23

Ultra Low Dose Radiation Therapy in Treating Patients With Mycosis Fungoides

Phase: N/A Priority: Normal
NCT ID: NCT03398161 Org: User:
Start: 01/06/18 End: 12/31/27 Due: 12/31/28

Combination Chemotherapy With Ketoconazole in Treating Patients With Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00003084 Org: User:
Start: 12/31/97 End: 11/30/02 Due: 11/30/03

Rectal Administration of Opioids Using the Macy Catheter in Reducing Pain in Patients With Advanced Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03592459 Org: User:
Start: 08/08/18 End: 01/15/20 Due: 01/15/21

Very Low Nicotine Content Cigarettes and E-Cigarettes in Promoting Smoking Cessation in Daily and Intermittent Cigarette Smokers

Phase: N/A Priority: Normal
NCT ID: NCT02964182 Org: User:
Start: 10/26/17 End: 03/04/25 Due: 03/04/26

FDG PET Imaging in Diagnosing Patients With Glioblastoma

Phase: N/A Priority: Normal
NCT ID: NCT02885272 Org: User:
Start: 10/28/16 End: 07/12/22 Due: 07/12/23

Simulation-Based Caregiving Skills Training for Family Members of High Grade Glioma Patients

Phase: N/A Priority: Normal
NCT ID: NCT05511324 Org: User:
Start: 10/21/22 End: 08/31/26 Due: 08/31/27